In partnership with the WHO Country Office in Turkey the PQ Team held an EUL Workshop on the 28 April 2022 with IVD regulators from the national regulatory authority TITCK and IVD manufacturers based in Turkey. The aim of this workshop was to provide manufacturers and regulators involved with assessment of IVDs for national registration and/or emergency use listing a comprehensive understanding of the EUL process, focusing on diagnostics for SARS-CoV-2. Presentations were delivered by WHO on the components of the EUL assessment and the role of independent laboratory evaluations. A Q&A session was held addressing the differences between PQ and EUL, the format of pre-submission meetings, assessment timelines and the requirements for EUL of SARS-CoV-2 IVDs compared to national and regional regulatory requirements. A summary of the Q&A discussion can be viewed below. The PQ Team would like to thank the participants for the fruitful discussion.